Shree Ganesh Biotech (India) Ltd
Shree Ganesh Biotech (India) Ltd Share Price Chart
Shree Ganesh Biotech (India) Ltd last traded at ₹0.46 (2026-10-13). Over the past month the stock moved -8.0%, three months the stock moved -24.6%, year the stock moved -41.8%. Its closing range over 52 weeks is ₹0.46 – ₹0.75, with the latest close 38.7% below the high.
Closing prices up to 2026-10-13.
About Shree Ganesh Biotech (India) Ltd
Incorporated in 1982, Shree Ganesh Biotech Ltd is engaged in the trading of seeds and bhushi.[1]
Business Overview:[1][2] SGBL is engaged in the business of production, processing and marketing of high-quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc. The company provides crop solutions to the farmer by supplying high yielding hybrid seeds and crop management namely micro nutrients, bio products etc.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Shree Ganesh Biotech (India) Ltd reported sales of ₹1.43 crore (+3.6%) and net profit of ₹-0.57 crore (-272.7%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 1.43 | -0.89 | -62.24 | -0.57 | -0.01 |
| Mar 2026 | 2.12 | -0.43 | -20.28 | -0.15 | 0.00 |
| Dec 2025 | 0.70 | -0.05 | -7.14 | 0.32 | 0.01 |
| Sep 2025 | 0.77 | -0.40 | -51.95 | 0.01 | 0.00 |
| Jun 2025 | 1.38 | -0.09 | -6.52 | 0.33 | 0.01 |
| Mar 2025 | 3.01 | -1.42 | -47.18 | -0.95 | -0.02 |
| Dec 2024 | 14.41 | 0.47 | 3.26 | 0.77 | 0.02 |
| Sep 2024 | 1.98 | 0.02 | 1.01 | 0.32 | 0.01 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -51.9% | +249.8% | -20.4% | -61.2% | -61.1% | -95.1% | -29.6% | +3.6% |
| Operating profit growth | -75.0% | +422.2% | – | – | -2100.0% | -110.6% | – | – |
| Net profit growth | +300.0% | +755.6% | -275.9% | +37.5% | -96.9% | -58.4% | – | -272.7% |
| EPS growth | – | – | -300.0% | +0.0% | -100.0% | -50.0% | – | -200.0% |
| OPM % | 1.0% | 3.3% | -47.2% | -6.5% | -52.0% | -7.1% | -20.3% | -62.2% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Shree Ganesh Biotech (India) Ltd reported sales of ₹4.97 crore (-78.4%) and net profit of ₹0.38 crore (+35.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 4.97 | -0.96 | -19.32 | 0.38 | 0.01 |
| Mar 2025 | 22.96 | -1.05 | -4.57 | 0.28 | 0.01 |
| Mar 2024 | 20.28 | -0.20 | -0.99 | 0.62 | 0.02 |
| Mar 2023 | 62.45 | 2.15 | 3.44 | 2.04 | 0.05 |
| Mar 2022 | 72.64 | 3.45 | 4.75 | 2.53 | 0.06 |
| Mar 2021 | 17.21 | 0.71 | 4.13 | 0.32 | 0.01 |
| Mar 2020 | 2.47 | 0.24 | 9.72 | 0.24 | 0.01 |
| Mar 2019 | 5.87 | 1.79 | 30.49 | 1.79 | 0.04 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -25.3% | -57.9% | +596.8% | +322.1% | -14.0% | -67.5% | +13.2% | -78.4% |
| Operating profit growth | -48.9% | -86.6% | +195.8% | +385.9% | -37.7% | -109.3% | – | – |
| Net profit growth | -48.9% | -86.6% | +33.3% | +690.6% | -19.4% | -69.6% | -54.8% | +35.7% |
| EPS growth | -95.8% | -75.0% | +0.0% | +500.0% | -16.7% | -60.0% | -50.0% | +0.0% |
| OPM % | 30.5% | 9.7% | 4.1% | 4.8% | 3.4% | -1.0% | -4.6% | -19.3% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
AI Analysis
No AI analysis generated yet for Shree Ganesh Biotech (India) Ltd.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Shree Ganesh Biotech (India) Ltd.
Frequently Asked Questions
What is Shree Ganesh Biotech (India) Ltd's current stock price?
Shree Ganesh Biotech (India) Ltd shares were last quoted at ₹0.46 (-2.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Shree Ganesh Biotech (India) Ltd?
Shree Ganesh Biotech (India) Ltd has a price-to-earnings (P/E) ratio of -47.00 and a price-to-book (P/B) ratio of 0.30. The industry P/E is 25.24.
What is the 52-week high and low of Shree Ganesh Biotech (India) Ltd?
The 52-week high of Shree Ganesh Biotech (India) Ltd is ₹0.78 and the 52-week low is ₹0.46.
What is the market cap of Shree Ganesh Biotech (India) Ltd?
The market capitalisation of Shree Ganesh Biotech (India) Ltd is about ₹18.74 crore.
How did Shree Ganesh Biotech (India) Ltd perform in its latest quarterly results?
In the latest quarter (Jun 2026), Shree Ganesh Biotech (India) Ltd reported sales of ₹1.43 crore (+3.6%) and net profit of ₹-0.57 crore (-272.7%), compared with the same quarter last year.
Is Shree Ganesh Biotech (India) Ltd a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Shree Ganesh Biotech (India) Ltd has a 3-year ROE of 1.00%, 3-year profit growth of -43.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Which sector does Shree Ganesh Biotech (India) Ltd belong to?
Shree Ganesh Biotech (India) Ltd belongs to the Agriculture sector.